Minneapolis-Based MGK Sells Subsidiary To UK Company
MINNEAPOLIS, Oct. 5, 2012 /PRNewswire/ -- MGK, the family-owned provider of insect control solutions to a wide variety of markets, announced the sale of one of its subsidies, Baltimore-based ICR Inc., to i2L Research Ltd. ("i2L") of Cardiff, UK.
ICR Inc, formerly known as Insect Control and Research, provides efficacy testing and regulation consulting to the insect control product industry. According to MGK President Steve Gullickson, the purchase of ICR by i2L, a product testing and development company also in the pest control industry, will help the UK organization extend its business from Europe into the United States.
"We certainly have appreciated, and will continue to appreciate, ICR's efficacy testing expertise, Gullickson said. "They provide an important service to us, and we look forward to being their customer in the coming years."
The sale of ICR strengthens MGK's strategic focus on its core business of creating responsible insect control products that protect people and their environments, added Gullickson. "We are very pleased to find a strategic buyer in i2L Research Ltd."
Dr Peter M cEwen, CEO of i2L, stated that "the acquisition of ICR, Inc., which will now trade as i2LResearch USA, Inc., is a hugely important development, which places us at the heart of the two most important economies in the world, the EU and the USA" About MGKFounded in 1902, MGK sells insect control products into global markets including consumer home and pet products, professional pest control, animal health, and crop protection. The company holds 253 product registrations with the EPA for insect control products, and currently sells its products into more than 60 countries globally . MGK is a world leader in the development and distribution of the botanical insecticide pyrethrin as well as a wide range of synthetic chemistries. For more information, visit www.mgk.com.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
